Ultra-fast label-free quantification and comprehensive proteome coverage with narrow-window data-independent acquisition.


Journal

Nature biotechnology
ISSN: 1546-1696
Titre abrégé: Nat Biotechnol
Pays: United States
ID NLM: 9604648

Informations de publication

Date de publication:
01 Feb 2024
Historique:
received: 14 06 2023
accepted: 13 12 2023
medline: 2 2 2024
pubmed: 2 2 2024
entrez: 1 2 2024
Statut: aheadofprint

Résumé

Mass spectrometry (MS)-based proteomics aims to characterize comprehensive proteomes in a fast and reproducible manner. Here we present the narrow-window data-independent acquisition (nDIA) strategy consisting of high-resolution MS1 scans with parallel tandem MS (MS/MS) scans of ~200 Hz using 2-Th isolation windows, dissolving the differences between data-dependent and -independent methods. This is achieved by pairing a quadrupole Orbitrap mass spectrometer with the asymmetric track lossless (Astral) analyzer which provides >200-Hz MS/MS scanning speed, high resolving power and sensitivity, and low-ppm mass accuracy. The nDIA strategy enables profiling of >100 full yeast proteomes per day, or 48 human proteomes per day at the depth of ~10,000 human protein groups in half-an-hour or ~7,000 proteins in 5 min, representing 3× higher coverage compared with current state-of-the-art MS. Multi-shot acquisition of offline fractionated samples provides comprehensive coverage of human proteomes in ~3 h. High quantitative precision and accuracy are demonstrated in a three-species proteome mixture, quantifying 14,000+ protein groups in a single half-an-hour run.

Identifiants

pubmed: 38302753
doi: 10.1038/s41587-023-02099-7
pii: 10.1038/s41587-023-02099-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Novo Nordisk Fonden (Novo Nordisk Foundation)
ID : NNF14CC0001
Organisme : Novo Nordisk Fonden (Novo Nordisk Foundation)
ID : NNF16CC0020906
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
ID : MSmed-686547
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
ID : EPIC-XS-823839
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
ID : PUSHH-861389
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
ID : HighResCells-810057
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
ID : PUSHH-861389
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
ID : MSmed-686547
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
ID : MSmed-686547

Informations de copyright

© 2024. The Author(s).

Références

Martinez-Val, A., Guzmán, U. H. & Olsen, J. V. Obtaining complete human proteomes. Annu. Rev. Genomics Hum. Genet. 23, 99–121 (2022).
pubmed: 35440146 doi: 10.1146/annurev-genom-112921-024948
Eliuk, S. & Makarov, A. Evolution of Orbitrap mass spectrometry instrumentation. Annu. Rev. Anal. Chem. https://doi.org/10.1146/annurev-anchem-071114-040325 (2015).
Sinitcyn, P. et al. Global detection of human variants and isoforms by deep proteome sequencing. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01714-x (2023).
doi: 10.1038/s41587-023-01714-x pubmed: 36959352 pmcid: 10713452
Bekker-Jensen, D. B. et al. An optimized shotgun strategy for the rapid generation of comprehensive human proteomes. Cell Syst. 4, 587–599.e4 (2017).
pubmed: 28601559 pmcid: 5493283 doi: 10.1016/j.cels.2017.05.009
Branca, R. M. M. et al. HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics. Nat. Methods 11, 59–62 (2014).
pubmed: 24240322 doi: 10.1038/nmeth.2732
Van Puyvelde, B. et al. A comprehensive LFQ benchmark dataset on modern day acquisition strategies in proteomics. Sci. Data 9, 126 (2022).
pubmed: 35354825 pmcid: 8967878 doi: 10.1038/s41597-022-01216-6
Fröhlich, K. et al. Benchmarking of analysis strategies for data-independent acquisition proteomics using a large-scale dataset comprising inter-patient heterogeneity. Nat. Commun. 13, 2622 (2022).
pubmed: 35551187 pmcid: 9098472 doi: 10.1038/s41467-022-30094-0
Messner, C. B. et al. Ultra-fast proteomics with Scanning SWATH. Nat. Biotechnol. 39, 846–854 (2021).
pubmed: 33767396 pmcid: 7611254 doi: 10.1038/s41587-021-00860-4
Skowronek, P. et al. Synchro-PASEF allows precursor-specific fragment ion extraction and interference removal in data-independent acquisition. Mol. Cell. Proteomics 22, 100489 (2023).
pubmed: 36566012 doi: 10.1016/j.mcpro.2022.100489
Meier, F. et al. Online parallel accumulation–serial fragmentation (PASEF) with a novel trapped ion mobility mass spectrometer. Mol. Cell. Proteomics 17, 2534–2545 (2018).
pubmed: 30385480 pmcid: 6283298 doi: 10.1074/mcp.TIR118.000900
Yu, F. et al. Analysis of DIA proteomics data using MSFragger-DIA and FragPipe computational platform. Nat. Commun. 14, 4154 (2023).
pubmed: 37438352 pmcid: 10338508 doi: 10.1038/s41467-023-39869-5
Stewart, H. I. et al. Parallelized acquisition of orbitrap and Astral analyzers enables high-throughput quantitative analysis. Anal. Chem. 95, 15656–15664 (2023).
Bekker-Jensen, D. B. et al. A compact quadrupole-Orbitrap mass spectrometer with FAIMS interface improves proteome coverage in short LC gradients. Mol. Cell. Proteomics 19, 716–729 (2020).
pubmed: 32051234 pmcid: 7124470 doi: 10.1074/mcp.TIR119.001906
Petrosius, V. et al. Evaluating the capabilities of the Astral mass analyzer for single-cell proteomics. Preprint at bioRxiv https://doi.org/10.1101/2023.06.06.543943 (2023).
Heil, L. R. et al. Evaluating the performance of the Astral mass analyzer for quantitative proteomics using data-independent acquisition. J. Proteome Res. 22, 3290–3300 (2023).
Olsen, J. V. et al. Higher-energy C-Trap dissociation for peptide modification analysis. Nat. Methods 4, 709–712 (2007).
pubmed: 17721543 doi: 10.1038/nmeth1060
Amodei, D. et al. Improving precursor selectivity in data-independent acquisition using overlapping windows. J. Am. Soc. Mass Spectrom. 30, 669–684 (2019).
pubmed: 30671891 pmcid: 6445824 doi: 10.1007/s13361-018-2122-8
Tabb, D. L. et al. Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. J. Proteome Res. 9, 761–776 (2010).
Granholm, V., Noble, W. S. & Käll, L. On using samples of known protein content to assess the statistical calibration of scores assigned to peptide-spectrum matches in shotgun proteomics. J. Proteome Res. 10, 2671–2678 (2011).
pubmed: 21391616 pmcid: 3268674 doi: 10.1021/pr1012619
Scherl, A. et al. On the benefits of acquiring peptide fragment ions at high measured mass accuracy. J. Am. Soc. Mass Spectrom. 19, 891–901 (2008).
pubmed: 18417358 pmcid: 2459323 doi: 10.1016/j.jasms.2008.02.005
Michalski, A. et al. Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC MS/MS and versatile peptide fragmentation modes. Mol. Cell. Proteomics 11, O111.013698 (2012).
pubmed: 22159718 doi: 10.1074/mcp.O111.013698
De Godoy, L. M. F. et al. Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 455, 1251–1254 (2008).
pubmed: 18820680 doi: 10.1038/nature07341
Hebert, A. S. et al. The one hour yeast proteome. Mol. Cell. Proteomics 13, 339–347 (2014).
pubmed: 24143002 doi: 10.1074/mcp.M113.034769
Kelstrup, C. D. et al. Optimized fast and sensitive acquisition methods for shotgun proteomics on a quadrupole Orbitrap mass spectrometer. J. Proteome Res. 11, 3487–3497 (2012).
pubmed: 22537090 doi: 10.1021/pr3000249
Feng, Y., Cappelletti, V. & Picotti, P. Quantitative proteomics of model organisms. Curr. Opin. Syst. Biol. https://doi.org/10.1016/j.coisb.2017.09.004 (2017).
Nielsen, M. L., Savitski, M. M. & Zubarev, R. A. Extent of modifications in human proteome samples and their effect on dynamic range of analysis in shotgun proteomics. Mol. Cell. Proteomics 5, 2384–2391 (2006).
pubmed: 17015437 doi: 10.1074/mcp.M600248-MCP200
Wang, Z. et al. High-throughput proteomics of nanogram-scale samples with Zeno SWATH MS. eLife 11, e83947 (2022).
pubmed: 36449390 pmcid: 9711518 doi: 10.7554/eLife.83947
Tüshaus, J. et al. A region‐resolved proteomic map of the human brain enabled by high‐throughput proteomics. EMBO J. 2, e114665 (2023).
Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics. 13, 2513–2526 (2014).
pubmed: 24942700 pmcid: 4159666 doi: 10.1074/mcp.M113.031591
Ahrné, E., Molzahn, L., Glatter, T. & Schmidt, A. Critical assessment of proteome-wide label-free absolute abundance estimation strategies. Proteomics 13, 2567–2578 (2013).
pubmed: 23794183 doi: 10.1002/pmic.201300135
Batth, T. S., Francavilla, C. & Olsen, J. V. Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics. J. Proteome Res. 13, 6176–6186 (2014).
pubmed: 25338131 doi: 10.1021/pr500893m
Kelstrup, C. D. et al. Rapid and deep proteomes by faster sequencing on a benchtop quadrupole ultra-high-field Orbitrap mass spectrometer. J. Proteome Res. 13, 6187–6195 (2014).
pubmed: 25349961 doi: 10.1021/pr500985w
Tsitsiridis, G. et al. CORUM: the comprehensive resource of mammalian protein complexes—2022. Nucleic Acids Res. 51, D539–D545 (2023).
pubmed: 36382402 doi: 10.1093/nar/gkac1015
Giurgiu, M. et al. CORUM: the comprehensive resource of mammalian protein complexes—2019. Nucleic Acids Res. 47, D559–D563 (2019).
pubmed: 30357367 doi: 10.1093/nar/gky973
de Godoy, L. M. F. et al. Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system. Genome Biol. 7, R50 (2006).
pubmed: 16784548 pmcid: 1779535 doi: 10.1186/gb-2006-7-6-r50
Sharma, K. et al. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 8, 1583–1594 (2014).
pubmed: 25159151 doi: 10.1016/j.celrep.2014.07.036
Olsen, J. V. et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. 3, ra3 (2010).
pubmed: 20068231 doi: 10.1126/scisignal.2000475
Martinez-Val, A. et al. Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution. Nat. Commun. 12, 7113 (2021).
pubmed: 34876567 pmcid: 8651693 doi: 10.1038/s41467-021-27398-y
Przybyla, L. & Gilbert, L. A. A new era in functional genomics screens. Nat. Rev. Genet. https://doi.org/10.1038/s41576-021-00409-w (2022).
Messner, C. B. et al. The proteomic landscape of genome-wide genetic perturbations. Cell 186, 2018–2034.e21 (2023).
Salvesen, L. et al. Neocortical neuronal loss in patients with multiple system atrophy: a stereological study. Cereb. Cortex 27, 400–410 (2017).
pubmed: 26464477
Monzio Compagnoni, G. & Di Fonzo, A. Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectives. Acta Neuropathol. Commun. https://doi.org/10.1186/s40478-019-0730-6 (2019).
Rydbirk, R. et al. Brain proteome profiling implicates the complement and coagulation cascade in multiple system atrophy brain pathology. Cell. Mol. Life Sci. 79, 336 (2022).
pubmed: 35657417 pmcid: 9164190 doi: 10.1007/s00018-022-04378-z
Glat, M. J., Stefanova, N., Wenning, G. K. & Offen, D. Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy. J. Neural Transm. 127, 205–212 (2020).
pubmed: 32065333 doi: 10.1007/s00702-020-02158-2
Xia, N., Cabin, D. E., Fang, F. & Reijo Pera, R. A. Parkinson’s disease: overview of transcription factor regulation, genetics, and cellular and animal models. Front. Neurosci. https://doi.org/10.3389/fnins.2022.894620 (2022).
Rafiee, M. R., Rohban, S., Davey, K., Ule, J. & Luscombe, N. M. RNA polymerase II-associated proteins reveal pathways affected in VCP-related amyotrophic lateral sclerosis. Brain 146, 2547–2556 (2023).
pubmed: 36789492 pmcid: 7614746 doi: 10.1093/brain/awad046
Meier, F. et al. diaPASEF: parallel accumulation–serial fragmentation combined with data-independent acquisition. Nat. Methods 17, 1229–1236 (2020).
pubmed: 33257825 doi: 10.1038/s41592-020-00998-0
Burns, A. P. et al. A universal and high-throughput proteomics sample preparation platform. Anal. Chem. 93, 8423–8431 (2021).
pubmed: 34110797 pmcid: 9876622 doi: 10.1021/acs.analchem.1c00265
Batth, T. S. et al. Protein aggregation capture on microparticles enables multipurpose proteomics sample preparation. Mol. Cell. Proteomics 18, 1027–1035 (2019).
pubmed: 30833379 pmcid: 6495262 doi: 10.1074/mcp.TIR118.001270
Chernushevich, I. V., Merenbloom, S. I., Liu, S. & Bloomfield, N. A W-geometry ortho-TOF MS with high resolution and up to 100% duty cycle for MS/MS. J. Am. Soc. Mass Spectrom. 28, 2143–2150 (2017).
pubmed: 28717932 doi: 10.1007/s13361-017-1742-8
Martínez-Val, A. et al. Hybrid-DIA: intelligent data acquisition integrates targeted and discovery proteomics to analyze phospho-signaling in single spheroids. Nat. Commun. 14, 3599 (2023).
pubmed: 37328457 pmcid: 10276052 doi: 10.1038/s41467-023-39347-y
Peng, J., Elias, J. E., Thoreen, C. C., Licklider, L. J. & Gygi, S. P. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J. Proteome Res. 2, 43–50 (2003).
pubmed: 12643542 doi: 10.1021/pr025556v
Washburn, M. P., Wolters, D. & Yates, J. R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242–247 (2001).
pubmed: 11231557 doi: 10.1038/85686
Thakur, S. S. et al. Deep and highly sensitive proteome coverage by LC-MS/MS without prefractionation. Mol. Cell. Proteomics 10, M110.003699 (2011).
Nagaraj, N. et al. System-wide perturbation analysis with nearly complete coverage of the yeast proteome by single-shot ultra HPLC runs on a bench top Orbitrap. Mol. Cell. Proteomics 11, M111.013722 (2012).
pubmed: 22021278 doi: 10.1074/mcp.M111.013722
Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41–44 (2020).
pubmed: 31768060 doi: 10.1038/s41592-019-0638-x
Pham, T. V., Henneman, A. A. & Jimenez, C. R. iq: an R package to estimate relative protein abundances from ion quantification in DIA-MS-based proteomics. Bioinformatics 36, 2611–2613 (2020).
pubmed: 31909781 pmcid: 7178409 doi: 10.1093/bioinformatics/btz961
Bekker-Jensen, D. B. et al. Rapid and site-specific deep phosphoproteome profiling by data-independent acquisition without the need for spectral libraries. Nat. Commun. 11, 787 (2020).
pubmed: 32034161 pmcid: 7005859 doi: 10.1038/s41467-020-14609-1
Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
pubmed: 34557778 pmcid: 8454663

Auteurs

Ulises H Guzman (UH)

Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Ana Martinez-Val (A)

Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Zilu Ye (Z)

Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
State Key Laboratory of Common Mechanism Research for Major Diseases, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, China.

Eugen Damoc (E)

Thermo Fisher Scientific (Bremen) GmbH, Bremen, Germany.

Tabiwang N Arrey (TN)

Thermo Fisher Scientific (Bremen) GmbH, Bremen, Germany.

Anna Pashkova (A)

Thermo Fisher Scientific (Bremen) GmbH, Bremen, Germany.

Santosh Renuse (S)

Thermo Fisher Scientific, San Jose, CA, USA.

Eduard Denisov (E)

Thermo Fisher Scientific (Bremen) GmbH, Bremen, Germany.

Johannes Petzoldt (J)

Thermo Fisher Scientific (Bremen) GmbH, Bremen, Germany.

Amelia C Peterson (AC)

Thermo Fisher Scientific (Bremen) GmbH, Bremen, Germany.

Florian Harking (F)

Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Ole Østergaard (O)

Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.

Rasmus Rydbirk (R)

Center for Functional Genomics and Tissue Plasticity (ATLAS), Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.

Susana Aznar (S)

Centre for Neuroscience and Stereology, Copenhagen University Hospital, Copenhagen, Denmark.

Hamish Stewart (H)

Thermo Fisher Scientific (Bremen) GmbH, Bremen, Germany.

Yue Xuan (Y)

Thermo Fisher Scientific (Bremen) GmbH, Bremen, Germany.

Daniel Hermanson (D)

Thermo Fisher Scientific, San Jose, CA, USA.

Stevan Horning (S)

Thermo Fisher Scientific (Bremen) GmbH, Bremen, Germany.

Christian Hock (C)

Thermo Fisher Scientific (Bremen) GmbH, Bremen, Germany.

Alexander Makarov (A)

Thermo Fisher Scientific (Bremen) GmbH, Bremen, Germany.

Vlad Zabrouskov (V)

Thermo Fisher Scientific, San Jose, CA, USA.

Jesper V Olsen (JV)

Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark. jesper.olsen@cpr.ku.dk.

Classifications MeSH